Wednesday, October 26, 2016
Video: Page (1) of 1 - 09/03/13 Email this story to a friend. email article Print this page (Article printing at page facebook
Analyst Moves: PFE, VZ, MU

By DMO Affiliate
This morning, Leerink Swann increased its price target on shares of Pfizer (PFE) to $28.50 as international sales of Lyrica could boost earnings at the pharmaceutical giant. In the report, Leerink increased its EPS estimates and maintained its market perform rating.
Analyst Moves: PFE, VZ, MU

Page: 1


Our Privacy Policy --- About The U.S. Daily News - Contact Us - Advertise With Us - Privacy Guidelines